Reuters exclusively reports G20 snubs COVID patent waiver, waters down pledge on WHO’s funding

Reuters reported exclusively that leaders of the world’s largest economies back “voluntary licensing” of COVID-19 vaccine patents, the drafted conclusions of the Global Health Summit show, watering down a U.S. push for waivers and earlier commitments to supply more funds to the World Health Organization. The draft document, seen by Reuters, is the result of a compromise among experts from G20 nations which remain divided over the waiving of intellectual property rights for COVID-19 vaccines.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Global
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story
Sign up for email updates

Sign up for email updates